AzTrials
AzTrials

Jaw, Edentulous, PartiallyNCT00820235

Study Comparing Appearance and Function of Three Different Dental Implant Designs When Placed in Front Region of Upper Jaw

A study testing OsseoSpeed™, NobelSpeedy™ Replace® and NanoTite™ Certain® PREVAIL® in people with Jaw, Edentulous, Partially, run by Dentsply Sirona Implants and Consumables at 4 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective is to compare the gum response to three different dental implant designs when placed in the front region of the upper jaw. The changes from baseline to one year after will be compared. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Jaw, Edentulous, Partially
What is being tested?
OsseoSpeed™, NobelSpeedy™ Replace® and NanoTite™ Certain® PREVAIL®
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
141 participants
Where
4 sitesin 2 countries
Study dates
Feb 2009to Sep 2016
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Provision of informed consent
  • At least 18 years
  • In need of one or more single implants replacing missing or non-restorable teeth in the maxilla within region 14 to 24
  • The following should be considered at inclusion but can not be fulfilled until at Visit 2:
  • Edentulous for at least 5 months at study site
  • A buccal-lingual bone width at study site of at least 5.5 mm
Show all 11Show fewer
  • A mesial-distal bone level distance between adjacent teeth at study site of at least 5.5 mm
  • A keratinized mid-buccal mucosal height of at least 2 mm at study site
  • Teeth adjacent (mesial and distal) to study site must consist of two stable teeth on natural roots without signs of periodontal bone loss (>1 mm) and/or significant soft tissue loss
  • Teeth adjacent (mesial and distal) to study site must demonstrate a stable occlusal guidance that will allow non-functional disclusion in all eccentric positions
  • An opposing dentition with teeth, implants or prosthesis

Who cannot join

  • Insufficient interocclusal distance for implant placement and restoration at study site
  • Tooth adjacent (mesial and/or distal) to study site is ankylosed
  • More than 2 mm vertical bone loss at study site as measured from the mid-buccal crest of bone on the adjacent teeth
  • Site development (bone tissue) performed at less than 5 months before Visit 2 at study site
  • Untreated rampant caries and/or uncontrolled periodontal disease
  • Class II division 2 malocclusion (Edward Hartley Angle)
Show all 18Show fewer
  • Use of tobacco within last 6 months
  • Uncontrolled diabetes (subjects history does not reveal the absence of control of insulin-dependent/non-insulin dependent Diabetes Mellitus)
  • Current alcohol or drug abuse
  • Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration
  • Use of any substance that will influence bone metabolism
  • Need for systemic corticosteroids or any other medication that would influence post-operative healing and/or osseointegration
  • History of radiation in the head and neck region
  • Known pregnancy, pregnancy tests will be performed as per local requirements.
  • Unable or unwilling to return for follow-up visits for a period of 5 years
  • Unlikely to be able to comply with study procedures according to Investigators judgement
  • Involvement in the planning and conduct of the study (applies to both Astra Tech staff or staff at the study center)
  • Previous enrollment or randomization of treatment in the present study.

Trial locations and contacts

4 sites in 2 countries.

4 sites in 2 countries

United States3 sites
  • University of North Carolina, School of Dentistry

    Chapel Hill, North Carolina, 27599-7450

  • Perio Health Clinical Research Center

    Houston, Texas, 77063

  • University of Iowa, College of Dentistry

    Iowa City, Iowa, 52242-1010

Other trials in United States

Canada1 site
  • Faculty of Dentistry, McGill University

    Montreal, Quebec, H3A 2K6

Other trials in Canada

About this study

Official title: Prospective, Comparative Assessment of Single-tooth Replacement in Different Implant-abutment Settings

The primary objective is to compare the gum response to three different dental implant designs when placed in the front region of the upper jaw. The changes from baseline to one year after will be compared. The null-hypothesis is that the buccal soft tissue (gum) changes from baseline to one year after are equal for all three implant-abutment interface settings.

Being tested
OsseoSpeed™, NobelSpeedy™ Replace®, NanoTite™ Certain® PREVAIL®
Medical subject headings
Jaw, Edentulous, Partially

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OsseoSpeed™Device

    OsseoSpeed™ implant

  • NobelSpeedy™ Replace®Device

    NobelSpeedy™ Replace® implant

  • NanoTite™ Certain® PREVAIL®Device

    NanoTite™ Certain® PREVAIL® implant

Study groups in NCT00820235
Study groupRoleWhat they receive
AExperimentalNot described
Receives: Device: OsseoSpeed™
BActive comparatorNot described
Receives: Device: NobelSpeedy™ Replace®
CActive comparatorNot described
Receives: Device: NanoTite™ Certain® PREVAIL®

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Buccal Soft Tissue (Gum) Changes, Measured as Mid-buccal Gingival Zenith (GZ) Scores.

    Soft tissue response was evaluated by measuring it clinically and by evaluating it from clinical photographs using image analysis. Clinical evaluations of gingival zenith were performed at time of loading (permanent restoration) and at the 5-year follow-up after loading.

    The vertical distance from the most apical aspect of the soft tissue margin to the incisal edge of implant crown was measured using a standardized periodontal probe to the nearest half millimeter using the surgical loupe. The changes in the gingival zenith was calculated for each study position and the average for each treatment group was calculated for the evaluation period.

    Measured: Evaluated at time of loading (permanent restoration) and at the 5-years follow-up after loading

Secondary outcomes (3)
  1. Marginal Bone Level Alterations

    Marginal Bone Level determined from radiographs and expressed as the difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. Marginal Bone Level expressed in millimeters at the 5-year follow-up visit compared to values obtained at time of implant placement.

    Measured: Evaluated at time of implant installation and at the 5-year follow-up visit.

  2. Evaluation of the Periimplant Mucosa Condition - By Assessment of PPD

    Condition of the periimplant mucosa by assessment of probing pocket depth (PPD).

    Change in pocket depth expressed in millimeters at the 5-year follow-up visit, compared to values obtained at delivery of permanent restoration, i.e. loading (baseline).

    Negative value = increased pocket depth.

    Measured: Measured at time of loading of permanent restoration and at the 5-year follow-up.

  3. Evaluation of the Periimplant Mucosa Condition - By Assessment of Change in BoP.

    Condition of the periimplant mucosa by assessment of Bleeding on Probing (BoP). Presented as change in proportion of surfaces that show presence of BoP, measured from implant loading to the 5-year follow-up visit.

    Measured: Measured at the implant loading and at the 5-year follow-up after loading.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2009 (estimated)
  2. Study startFeb 2009
  3. Primary completionSep 2016
  4. Study completionSep 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
141 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00820235
Sponsor's protocol ID
YA-OSS-0003
Status last verified
Apr 2020
First submitted
9 Jan 2009
Last updated
7 May 2020
Data monitoring committee
No

Publications

  • McGuire MK, Scheyer T, Ho DK, Stanford CM, Feine JS, Cooper LF. Esthetic outcomes in relation to implant-abutment interface design following a standardized treatment protocol in a multicenter randomized controlled trial--a cohort of 12 cases at 1-year follow-up. Int J Periodontics Restorative Dent. 2015 Mar-Apr;35(2):149-59. doi: 10.11607/prd.2341.

    PubMed 25738335
  • Cooper LF, Reside G, Stanford C, Barwacz C, Feine J, Abi Nader S, Scheyer ET, McGuire M. A multicenter randomized comparative trial of implants with different abutment interfaces to replace anterior maxillary single teeth. Int J Oral Maxillofac Implants. 2015 May-Jun;30(3):622-32. doi: 10.11607/jomi.3772.

    PubMed 26009913
  • Barwacz CA, Stanford CM, Diehl UA, Qian F, Cooper LF, Feine J, McGuire M. Electronic assessment of peri-implant mucosal esthetics around three implant-abutment configurations: a randomized clinical trial. Clin Oral Implants Res. 2016 Jun;27(6):707-15. doi: 10.1111/clr.12640. Epub 2015 Jun 21.

    PubMed 26096162

Questions about this trial

What is this clinical trial studying?

A study testing OsseoSpeed™, NobelSpeedy™ Replace® and NanoTite™ Certain® PREVAIL® in people with Jaw, Edentulous, Partially, run by Dentsply Sirona Implants and Consumables at 4 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States, Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 7 May 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Buccal Soft Tissue (Gum) Changes, Measured as Mid-buccal Gingival Zenith (GZ) Scores. (time frame: Evaluated at time of loading (permanent restoration) and at the 5-years follow-up after loading). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00820235, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in